What does this TikTok actually claim?
@skinbykristin posted a video about peptide therapy that's got 122K views, but without seeing the actual content, we can only work from her hashtags: #peptidetherapy, #glp1, #nad, and #antiagingtips. The combination suggests she's discussing peptides for anti-aging and possibly GLP-1 receptor agonists.
This hashtag mix is telling. It lumps together prescription medications (GLP-1 drugs like semaglutide) with research peptides and supplements. That's a red flag for oversimplification.
What's the actual science on peptide therapy?
The peptide therapy market is a mixed bag of legitimate medicine and unproven treatments. GLP-1 receptor agonists like semaglutide have solid evidence. The STEP 1 trial (Wilding et al., NEJM, 2021) showed 14.9% weight loss at 68 weeks with 2.4mg semaglutide weekly.
But popular "research peptides" like BPC-157 and TB-500 lack human clinical trials for anti-aging claims. A 2020 review in the Journal of Clinical Medicine found no published human studies supporting BPC-157's healing claims despite widespread online promotion.
NAD+ precursors have some preliminary data but nothing definitive for anti-aging in humans.
Where does peptide marketing go wrong?
Social media peptide content often treats all peptides as equally proven, which they're not. Prescription GLP-1 drugs undergo rigorous FDA testing while "research peptides" sold by compounding pharmacies exist in a regulatory gray area.
The FDA has issued warning letters to companies selling BPC-157 and similar peptides with unproven health claims. In 2022, they specifically called out marketing these as dietary supplements when they don't qualify.
Anti-aging claims are particularly problematic because aging isn't a disease you can treat with a single intervention.
What should you know about peptide safety?
Prescription peptides like GLP-1 drugs have known side effect profiles. Semaglutide causes nausea in about 44% of users at 2.4mg doses, according to STEP trial data.
Research peptides carry unknown risks because they lack proper safety testing. A 2023 analysis found that 41% of research peptide products contained different amounts than labeled, and 12% contained completely different compounds.
Compounding pharmacies aren't required to prove safety or efficacy before selling these products. That's a big difference from FDA-approved medications.
What's the bottom line on peptides?
Stick with proven treatments if you're serious about results. FDA-approved GLP-1 drugs work for weight management when prescribed appropriately. Everything else in the peptide space is mostly hype ahead of evidence.
The research peptide market preys on people wanting cutting-edge solutions before the science catches up. If BPC-157 or TB-500 actually delivered dramatic anti-aging benefits, pharmaceutical companies would have developed them into real drugs by now.
Save your money and talk to a doctor about proven options instead of chasing the latest peptide trend on social media.